ARTICLE | Top Story

Acambis reports earnings

May 11, 2005 1:06 AM UTC

Acambis (LSE:ACM;ACAM) reported a first quarter 2005 loss per share of 4.1p, compared with a 1.2p loss in the same period in 2004. First quarter revenues were L6 million ($11.3 million), down 68% from L18.8 million ($35.5 million) in the first quarter of 2004. The company said the decline reflects lower revenues from its CDC contract for ACAM2000 smallpox vaccine, which is nearing completion. ...